Compliance Rate
Compliance Rate
48.0%
Compliant submissions
48
Incompliant submissions
52
Total trials
100
Your Clinical Trials
Showing 539325 of 542236 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 08/01/20
Due: 08/01/21
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 11/03/17
Due: 11/03/18
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 01/13/25
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 10/31/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 08/01/25
Due: 08/01/26
Phase: N/A
Priority: Normal
Start: 05/01/25
End: 09/30/28
Due: 09/30/29
Phase: N/A
Priority: Normal
Start: 09/01/21
End: 08/19/22
Due: 08/19/23
Phase: N/A
Priority: Normal
Start: 03/14/22
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 12/31/24
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 10/31/25
End: 02/28/30
Due: 02/28/31
Phase: N/A
Priority: Normal
Start: 03/06/17
End: 03/06/32
Due: 03/06/33
Phase: N/A
Priority: Normal
Start: 12/02/24
End: 08/25/26
Due: 08/25/27
Phase: N/A
Priority: Normal
Start: 01/27/24
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 12/15/24
End: 02/22/25
Due: 02/22/26
SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.
Phase: N/A
Priority: Normal
Start: 03/03/23
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 02/22/23
End: 07/26/24
Due: 07/26/25
Phase: N/A
Priority: Normal
Start: 12/28/24
End: 03/30/25
Due: 03/30/26
Phase: N/A
Priority: Normal
Start: 11/30/13
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 03/01/22
Due: 03/01/23
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 11/30/13
Due: 11/30/14
Phase: N/A
Priority: Normal
Start: 12/13/23
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 09/09/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 06/13/16
End: 09/11/18
Due: 09/11/19
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -